NCT07351058 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes Status RECRUITING Phase PHASE3
NCT07351045 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes Status RECRUITING Phase PHASE3
NCT07347600 A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer Status RECRUITING Phase N/A
NCT07323576 A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT07298421 A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease Status RECRUITING Phase PHASE3
NCT07287150 A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE2
NCT07284121 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice Status RECRUITING Phase N/A
NCT07282574 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) Status RECRUITING Phase PHASE2
NCT07279402 TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50% Status RECRUITING Phase N/A
NCT07271693 A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants Status RECRUITING Phase PHASE1
NCT07246941 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease Status RECRUITING Phase PHASE1
NCT07234942 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD) Status RECRUITING Phase PHASE1
NCT07226206 A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A Status RECRUITING Phase PHASE1/PHASE2
NCT07223697 A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis Status RECRUITING Phase PHASE2
NCT07200375 An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma Status RECRUITING Phase N/A
NCT07191249 A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL). Status NOT_YET_RECRUITING Phase PHASE2
NCT07181109 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease Status RECRUITING Phase PHASE3
NCT07177352 Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies Status RECRUITING Phase PHASE3
NCT07174310 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease Status RECRUITING Phase PHASE3
NCT07172022 A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS) Status WITHDRAWN Phase PHASE2